Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The main effect of Osteoarthritis Pain Drugs is to relieve pain and osteoarthritis symptoms.
The Osteoarthritis Pain Drugs market is projected to reach USD 11.7 billion by 2026 from USD 6.3 billion in 2018, at a CAGR of 9%.
The growth of the market has been driven by the rapid growth of the elderly and obese population, as well as the increase in the prevalence of osteoarthritis.
This report elaborates on the current development of the Osteoarthritis Pain Drugs industry thoroughly based on the international market dynamics and China's market situation.
For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.
Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market.
Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.
By Player:
Johnson & Johnson
Bayer
Sanofi
Pfizer
TEVA
Iroko Pharmaceuticals
GlaxoSmithKline
Almatica Pharma
Mylan
By Type:
External
Oral
Injection
By Application:
Medical Care
Personal Care
By Research Region:
-
North China
-
Central China
-
South China
-
East China
-
Northeast China
-
Southwest China
-
Northwest China
TABLE OF CONTENT
Chapter 1 China Osteoarthritis Pain Drugs Market Overview 2018-2029
-
1.1 China Osteoarthritis Pain Drugs Industry Development Overview
-
1.2 China Osteoarthritis Pain Drugs Industry Development History
-
1.3 China Osteoarthritis Pain Drugs Industry Market Size (2018-2029)
-
1.4 China Osteoarthritis Pain Drugs Market Analysis by Type from Production Side
-
1.4.1 China Osteoarthritis Pain Drugs Production Volume, Production Value and Growth Rate of External (2018-2029)
-
1.4.2 China Osteoarthritis Pain Drugs Production Volume, Production Value and Growth Rate of Oral (2018-2029)
-
1.4.3 China Osteoarthritis Pain Drugs Production Volume, Production Value and Growth Rate of Injection (2018-2029)
-
1.5 China Osteoarthritis Pain Drugs Market Analysis by Application from Consumption End
-
1.5.1 China Osteoarthritis Pain Drugs Sales Volume, Sales Value and Growth Rate of Medical Care (2018-2029)
-
1.5.2 China Osteoarthritis Pain Drugs Sales Volume, Sales Value and Growth Rate of Personal Care (2018-2029)
-
1.6 China Osteoarthritis Pain Drugs Market Analysis by Region
-
1.6.1 North China Osteoarthritis Pain Drugs Market Size and Growth Rate from 2018-2029
-
1.6.2 Central China Osteoarthritis Pain Drugs Market Size and Growth Rate from 2018-2029
-
1.6.3 South China Osteoarthritis Pain Drugs Market Size and Growth Rate from 2018-2029
-
1.6.4 East China Osteoarthritis Pain Drugs Market Size and Growth Rate from 2018-2029
-
1.6.5 Northeast China Osteoarthritis Pain Drugs Market Size and Growth Rate from 2018-2029
-
1.6.6 Southwest China Osteoarthritis Pain Drugs Market Size and Growth Rate from 2018-2029
-
1.6.7 Northwest China Osteoarthritis Pain Drugs Market Size and Growth Rate from 2018-2029
Chapter 2 China Osteoarthritis Pain Drugs Industry Development Environment
-
2.1 Industry Development Environment Analysis
-
2.1.1 Industry Technological Progress Analysis
-
2.1.2 Industrial Organizational Innovation Analysis
-
2.1.3 Changes in Social Habits
-
2.1.4 Alterations in Government Policies
-
2.1.5 Impact of Economic Globalization
-
2.2 Domestic and Foreign Industry Competition Analysis
-
2.2.1 Comparative Analysis on Osteoarthritis Pain Drugs Market Status and Competition at home and abroad in 2023
-
2.2.2 China Osteoarthritis Pain Drugs Market Status and Competition Analysis in 2023
-
2.2.3 China Osteoarthritis Pain Drugs Market Concentration Analysis in 2023
-
2.3 Problems and Countermeasures in the development of China Osteoarthritis Pain Drugs Industry
-
2.3.1 Industry Development Constraints
-
2.3.2 Industry Development Considerations
-
2.3.3 Suggestions on Industry Development Measures
-
2.3.4 Development Strategies for SMEs
-
2.4 Influence of COVID-19 Outbreak on Osteoarthritis Pain Drugs Industry Development
Chapter 3 Osteoarthritis Pain DrugsIndustry Chain Analysis
-
3.1 Osteoarthritis Pain Drugs Industry Chain
-
3.2 Osteoarthritis Pain Drugs Upstream Industry Analysis
-
3.2.1 Upstream Industry Development Status
-
3.2.2 Upstream Industry Development Forecast
-
3.2.3 Impact of Upstream Industry on the Osteoarthritis Pain Drugs Market
-
3.3 Osteoarthritis Pain Drugs Downstream Industry Analysis
-
3.3.1 Downstream Industry Development Status
-
3.3.2 Downstream Industry Development Forecast
-
3.3.3 Impact of Downstream Industry on the Osteoarthritis Pain Drugs Market
Chapter 4 China Osteoarthritis Pain Drugs Market, by Type
-
4.1 China Osteoarthritis Pain Drugs Market Trend, by Type
-
4.2 Product Types of Major Suppliers
-
4.3 Competitive Landscape of Major Types
-
4.4 China Osteoarthritis Pain Drugs Total Production Volume and Growth Rate from Production Side
-
4.5 China Osteoarthritis Pain Drugs Production Volume and Growth Rate, by Type
-
4.5.1 China Osteoarthritis Pain Drugs Production Volume and Growth Rate of External
-
4.5.2 China Osteoarthritis Pain Drugs Production Volume and Growth Rate of Oral
-
4.5.3 China Osteoarthritis Pain Drugs Production Volume and Growth Rate of Injection
Chapter 5 China Osteoarthritis Pain Drugs Market, by Application
-
5.1 Downstream Market Overview
-
5.2 Competitive Landscape of Major Applications
-
5.3 Market Potential Analysis, by Application
-
5.4 China Osteoarthritis Pain Drugs Total Market Size and Growth Rate from Consumption End
-
5.5 China Osteoarthritis Pain Drugs Market Size and Growth Rate, by Application
-
5.5.1 China Osteoarthritis Pain Drugs Market Size and Growth Rate of Medical Care
-
5.5.2 China Osteoarthritis Pain Drugs Market Size and Growth Rate of Personal Care
Chapter 6 China Osteoarthritis Pain Drugs Market, by Region
-
6.1 China Osteoarthritis Pain Drugs Production Volume and Production Value, by Region
-
6.2 China Osteoarthritis Pain Drugs Sales Volume and Sales Value, by Region
Chapter 7 North China Osteoarthritis Pain Drugs Market Analysis
-
7.1 North China Osteoarthritis Pain Drugs Market, by Type
-
7.2 North China Osteoarthritis Pain Drugs Market, by Application
Chapter 8 Central China Osteoarthritis Pain Drugs Market Analysis
-
8.1 Central China Osteoarthritis Pain Drugs Market, by Type
-
8.2 Central China Osteoarthritis Pain Drugs Market, by Application
Chapter 9 South China Osteoarthritis Pain Drugs Market Analysis
-
9.1 South China Osteoarthritis Pain Drugs Market, by Type
-
9.2 South China Osteoarthritis Pain Drugs Market, by Application
Chapter 10 East China Osteoarthritis Pain Drugs Market Analysis
-
10.1 East China Osteoarthritis Pain Drugs Market, by Type
-
10.2 East China Osteoarthritis Pain Drugs Market, by Application
Chapter 11 Northeast China Osteoarthritis Pain Drugs Market Analysis
-
11.1 Northeast China Osteoarthritis Pain Drugs Market, by Type
-
11.2 Northeast China Osteoarthritis Pain Drugs Market, by Application
Chapter 12 Southwest China Osteoarthritis Pain Drugs Market Analysis
-
12.1 Southwest China Osteoarthritis Pain Drugs Market, by Type
-
12.2 Southwest China Osteoarthritis Pain Drugs Market, by Application
Chapter 13 Northwest China Osteoarthritis Pain Drugs Market Analysis
-
13.1 Northwest China Osteoarthritis Pain Drugs Market, by Type
-
13.2 Northwest China Osteoarthritis Pain Drugs Market, by Application
Chapter 14 Company Profiles
-
14.1 Johnson & Johnson
-
14.1.1 Johnson & Johnson Company Profile
-
14.1.2 Johnson & Johnson Osteoarthritis Pain Drugs Market Performance
-
14.1.3 Product&Service Introduction
-
14.2 Bayer
-
14.2.1 Bayer Company Profile
-
14.2.2 Bayer Osteoarthritis Pain Drugs Market Performance
-
14.2.3 Product&Service Introduction
-
14.3 Sanofi
-
14.3.1 Sanofi Company Profile
-
14.3.2 Sanofi Osteoarthritis Pain Drugs Market Performance
-
14.3.3 Product&Service Introduction
-
14.4 Pfizer
-
14.4.1 Pfizer Company Profile
-
14.4.2 Pfizer Osteoarthritis Pain Drugs Market Performance
-
14.4.3 Product&Service Introduction
-
14.5 TEVA
-
14.5.1 TEVA Company Profile
-
14.5.2 TEVA Osteoarthritis Pain Drugs Market Performance
-
14.5.3 Product&Service Introduction
-
14.6 Iroko Pharmaceuticals
-
14.6.1 Iroko Pharmaceuticals Company Profile
-
14.6.2 Iroko Pharmaceuticals Osteoarthritis Pain Drugs Market Performance
-
14.6.3 Product&Service Introduction
-
14.7 GlaxoSmithKline
-
14.7.1 GlaxoSmithKline Company Profile
-
14.7.2 GlaxoSmithKline Osteoarthritis Pain Drugs Market Performance
-
14.7.3 Product&Service Introduction
-
14.8 Almatica Pharma
-
14.8.1 Almatica Pharma Company Profile
-
14.8.2 Almatica Pharma Osteoarthritis Pain Drugs Market Performance
-
14.8.3 Product&Service Introduction
-
14.9 Mylan
-
14.9.1 Mylan Company Profile
-
14.9.2 Mylan Osteoarthritis Pain Drugs Market Performance
-
14.9.3 Product&Service Introduction
Chapter 15 Research Conclusions and Investment Suggestions
-
15.1 Osteoarthritis Pain Drugs Industry Research Conclusions
-
15.2 Osteoarthritis Pain Drugs Industry Investment Suggestions
-
15.2.1 Suggestions on Industry Development Strategy
-
15.2.2 Suggestions on Industry Investment Direction
-
15.2.3 Suggestions on Industry Investment Strategy
List of Tables and Figures
-
Figure China Osteoarthritis Pain Drugs Industry Market Size (2018-2029)
-
Figure China Osteoarthritis Pain Drugs Production Volume, Production Value and Growth Rate of External (2018-2029)
-
Figure China Osteoarthritis Pain Drugs Production Volume, Production Value and Growth Rate of Oral (2018-2029)
-
Figure China Osteoarthritis Pain Drugs Production Volume, Production Value and Growth Rate of Injection (2018-2029)
-
Figure China Osteoarthritis Pain Drugs Sales Volume, Sales Value and Growth Rate of Medical Care (2018-2029)
-
Figure China Osteoarthritis Pain Drugs Sales Volume, Sales Value and Growth Rate of Personal Care (2018-2029)
-
Figure North China Osteoarthritis Pain Drugs Market Size and Growth Rate from 2018-2029
-
Figure Central China Osteoarthritis Pain Drugs Market Size and Growth Rate from 2018-2029
-
Figure South China Osteoarthritis Pain Drugs Market Size and Growth Rate from 2018-2029
-
Figure East China Osteoarthritis Pain Drugs Market Size and Growth Rate from 2018-2029
-
Figure Northeast China Osteoarthritis Pain Drugs Market Size and Growth Rate from 2018-2029
-
Figure Southwest China Osteoarthritis Pain Drugs Market Size and Growth Rate from 2018-2029
-
Figure Northwest China Osteoarthritis Pain Drugs Market Size and Growth Rate from 2018-2029
-
Figure Osteoarthritis Pain Drugs Industry Chain
-
Table Product Types of Major Suppliers in 2023
-
Figure China Osteoarthritis Pain Drugs Market Share by Type in 2018
-
Figure China Osteoarthritis Pain Drugs Market Share by Type in 2023
-
Figure China Osteoarthritis Pain Drugs Total Production Volume and Growth Rate from Production Side (2018-2023)
-
Figure China Osteoarthritis Pain Drugs Production Volume and Growth Rate of External (2018-2023)
-
Figure China Osteoarthritis Pain Drugs Production Volume and Growth Rate of Oral (2018-2023)
-
Figure China Osteoarthritis Pain Drugs Production Volume and Growth Rate of Injection (2018-2023)
-
Figure China Osteoarthritis Pain Drugs Market Share by Application in 2018
-
Figure China Osteoarthritis Pain Drugs Market Share by Application in 2023
-
Figure China Osteoarthritis Pain Drugs Total Market Size and Growth Rate from Consumption End
-
Figure China Osteoarthritis Pain Drugs Market Size and Growth Rate of Medical Care (2018-2023)
-
Figure China Osteoarthritis Pain Drugs Market Size and Growth Rate of Personal Care (2018-2023)
-
Table China Osteoarthritis Pain Drugs Production Volume by Region (2018-2023)
-
Table China Osteoarthritis Pain Drugs Production Volume Share by Region (2018-2023)
-
Figure China Osteoarthritis Pain Drugs Production Volume Share by Region (2018-2023)
-
Table China Osteoarthritis Pain Drugs Production Value by Region (2018-2023)
-
Table China Osteoarthritis Pain Drugs Production Value Share by Region (2018-2023)
-
Figure China Osteoarthritis Pain Drugs Production Value Share by Region (2018-2023)
-
Table China Osteoarthritis Pain Drugs Sales Volume by Region (2018-2023)
-
Table China Osteoarthritis Pain Drugs Sales Volume Share by Region (2018-2023)
-
Figure China Osteoarthritis Pain Drugs Sales Volume Share by Region (2018-2023)
-
Table China Osteoarthritis Pain Drugs Sales Value by Region (2018-2023)
-
Table China Osteoarthritis Pain Drugs Sales Value Share by Region (2018-2023)
-
Figure China Osteoarthritis Pain Drugs Sales Value Share by Region (2018-2023)
-
Table North China Osteoarthritis Pain Drugs Production Volume by Type (2018-2023)
-
Table North China Osteoarthritis Pain Drugs Production Volume Share by Type (2018-2023)
-
Figure North China Osteoarthritis Pain Drugs Production Volume Share by Type (2018-2023)
-
Table North China Osteoarthritis Pain Drugs Sales Volume by Application (2018-2023)
-
Table North China Osteoarthritis Pain Drugs Sales Volume Share by Application (2018-2023)
-
Figure North China Osteoarthritis Pain Drugs Sales Volume Share by Application (2018-2023)
-
Table Central China Osteoarthritis Pain Drugs Production Volume by Type (2018-2023)
-
Table Central China Osteoarthritis Pain Drugs Production Volume Share by Type (2018-2023)
-
Figure Central China Osteoarthritis Pain Drugs Production Volume Share by Type (2018-2023)
-
Table Central China Osteoarthritis Pain Drugs Sales Volume by Application (2018-2023)
-
Table Central China Osteoarthritis Pain Drugs Sales Volume Share by Application (2018-2023)
-
Figure Central China Osteoarthritis Pain Drugs Sales Volume Share by Application (2018-2023)
-
Table South China Osteoarthritis Pain Drugs Production Volume by Type (2018-2023)
-
Table South China Osteoarthritis Pain Drugs Production Volume Share by Type (2018-2023)
-
Figure South China Osteoarthritis Pain Drugs Production Volume Share by Type (2018-2023)
-
Table South China Osteoarthritis Pain Drugs Sales Volume by Application (2018-2023)
-
Table South China Osteoarthritis Pain Drugs Sales Volume Share by Application (2018-2023)
-
Figure South China Osteoarthritis Pain Drugs Sales Volume Share by Application (2018-2023)
-
Table East China Osteoarthritis Pain Drugs Production Volume by Type (2018-2023)
-
Table East China Osteoarthritis Pain Drugs Production Volume Share by Type (2018-2023)
-
Figure East China Osteoarthritis Pain Drugs Production Volume Share by Type (2018-2023)
-
Table East China Osteoarthritis Pain Drugs Sales Volume by Application (2018-2023)
-
Table East China Osteoarthritis Pain Drugs Sales Volume Share by Application (2018-2023)
-
Figure East China Osteoarthritis Pain Drugs Sales Volume Share by Application (2018-2023)
-
Table Northeast China Osteoarthritis Pain Drugs Production Volume by Type (2018-2023)
-
Table Northeast China Osteoarthritis Pain Drugs Production Volume Share by Type (2018-2023)
-
Figure Northeast China Osteoarthritis Pain Drugs Production Volume Share by Type (2018-2023)
-
Table Northeast China Osteoarthritis Pain Drugs Sales Volume by Application (2018-2023)
-
Table Northeast China Osteoarthritis Pain Drugs Sales Volume Share by Application (2018-2023)
-
Figure Northeast China Osteoarthritis Pain Drugs Sales Volume Share by Application (2018-2023)
-
Table Southwest China Osteoarthritis Pain Drugs Production Volume by Type (2018-2023)
-
Table Southwest China Osteoarthritis Pain Drugs Production Volume Share by Type (2018-2023)
-
Figure Southwest China Osteoarthritis Pain Drugs Production Volume Share by Type (2018-2023)
-
Table Southwest China Osteoarthritis Pain Drugs Sales Volume by Application (2018-2023)
-
Table Southwest China Osteoarthritis Pain Drugs Sales Volume Share by Application (2018-2023)
-
Figure Southwest China Osteoarthritis Pain Drugs Sales Volume Share by Application (2018-2023)
-
Table Northwest China Osteoarthritis Pain Drugs Production Volume by Type (2018-2023)
-
Table Northwest China Osteoarthritis Pain Drugs Production Volume Share by Type (2018-2023)
-
Figure Northwest China Osteoarthritis Pain Drugs Production Volume Share by Type (2018-2023)
-
Table Northwest China Osteoarthritis Pain Drugs Sales Volume by Application (2018-2023)
-
Table Northwest China Osteoarthritis Pain Drugs Sales Volume Share by Application (2018-2023)
-
Figure Northwest China Osteoarthritis Pain Drugs Sales Volume Share by Application (2018-2023)
-
Table Johnson & Johnson Company Profile
-
Table Johnson & Johnson Osteoarthritis Pain Drugs Revenue, Price and Gross (2018-2023)
-
Table Bayer Company Profile
-
Table Bayer Osteoarthritis Pain Drugs Revenue, Price and Gross (2018-2023)
-
Table Sanofi Company Profile
-
Table Sanofi Osteoarthritis Pain Drugs Revenue, Price and Gross (2018-2023)
-
Table Pfizer Company Profile
-
Table Pfizer Osteoarthritis Pain Drugs Revenue, Price and Gross (2018-2023)
-
Table TEVA Company Profile
-
Table TEVA Osteoarthritis Pain Drugs Revenue, Price and Gross (2018-2023)
-
Table Iroko Pharmaceuticals Company Profile
-
Table Iroko Pharmaceuticals Osteoarthritis Pain Drugs Revenue, Price and Gross (2018-2023)
-
Table GlaxoSmithKline Company Profile
-
Table GlaxoSmithKline Osteoarthritis Pain Drugs Revenue, Price and Gross (2018-2023)
-
Table Almatica Pharma Company Profile
-
Table Almatica Pharma Osteoarthritis Pain Drugs Revenue, Price and Gross (2018-2023)
-
Table Mylan Company Profile
-
Table Mylan Osteoarthritis Pain Drugs Revenue, Price and Gross (2018-2023)
-
